Validity and comparison of two measures of days supply in medicaid claims data

Pharmacoepidemiology and Drug Safety

Volumn 17, Issue 10, 2008, Pages 1029-1032

  Gross, Robert ^a   Bilker, Warren B ^a   Strom, Brian L ^a   Hennessy, Sean ^a  

^a UNIVERSITY OF PENNSYLVANIA   (United States)

Author keywords

Claims data; Pharmacoepidemiology; Validation

Indexed keywords

ABACAVIR; ABACAVIR PLUS LAMIVUDINE PLUS ZIDOVUDINE; NEVIRAPINE;

ADULT; ARTICLE; CALCULATION; CONTROLLED STUDY; FEMALE; HUMAN; INTERMETHOD COMPARISON; MAJOR CLINICAL STUDY; MALE; MEDICAID; PATIENT COMPLIANCE; PHARMACOEPIDEMIOLOGY; PRESCRIPTION; PRIORITY JOURNAL; UNITED STATES; VALIDITY;

ADULT; CALIFORNIA; COHORT STUDIES; FEMALE; HUMANS; MALE; MEDICAID; MIDDLE AGED; PRESCRIPTION DRUGS; UNITED STATES; WEIGHTS AND MEASURES;

EID: 57649152957     PISSN: 10538569     EISSN: 10991557     Source Type: Journal    
DOI: 10.1002/pds.1606     Document Type: Article

References (12)

1. Carson J, Strom B. Medicaid databases. In Pharmacoepidemiology John Wiley & Sons: Chichester, 1994; 199-216.
2. Choo PW, Rand CS, Inui TS, et al. Validation of patient reports, automated pharmacy records, and pill counts with electronic monitoring of adherence to antihypertensive therapy. Med Care 1999; 37: 846-857.
3. Grossberg R, Zhang Y, Gross R. A time-to-prescription-refill measure of antiretroviral adherence predicted changes in viral load in HIV. J Clin Epidemiol 2004; 57: 1107-1110.
4. Gross R, Yip B, Re VL, 3rd, et al. A simple, dynamic measure of antiretroviral therapy adherence predicts failure to maintain HIV-1 suppression. J Infect Dis 2006; 194: 1108-1114.
5. Hetherington S, Hughes AR, Mosteller M, et al. Genetic variations in HLA-B region and hypersensitivity reactions to abacavir. Lancet 2002; 359: 1121-1122.
6. Phillips E, Gutierrez S, Jahnke N, et al. Determinants of nevirapine hypersensitivity and its effect on the association between hepatitis C status and mortality in antiretroviral drug-naive HIV-positive patients. AIDS 2007; 21: 1561-1568.
7. Steiner JF, Koepsell TD, Fihn SD, Inui TS. A general method of compliance assessment using centralized pharmacy records. Description and validation. Med Care 1988; 26: 814-823.
8. Gross R, Bilker WB, Friedman HM, Strom BL. Effect of adherence to newly initiated antiretroviral therapy on plasma viral load. AIDS 2001; 15: 2109-2117.
9. Bangsberg DR, Hecht FM, Charlebois ED, et al. Adherence to protease inhibitors, HIV-1 viral load, and development of drug resistance in an indigent population. AIDS 2000; 14: 357-366.
10. Paterson DL, Swindells S, Mohr J, et al. Adherence to protease inhibitor therapy and outcomes in patients with HIV infection. Ann Intern Med 2000; 133: 21-30.
11. Farris K, Kaplan B, Kirking D. Examination of days supply in comupertized prescription Claims. J Pharmacoepidemiol 1994; 3: 63-76.
12. Hammer SM, Saag MS, Schechter M, et al. Treatment for adult HIV infection: 2006 recommendations of the International AIDS Society-USA panel. JAMA 2006; 296: 827-843.